Products Categories
CAS No.: | 125-04-2 |
---|---|
Name: | Hydrocortisone sodium succinate |
Molecular Structure: | |
Formula: | C25H33NaO8 |
Molecular Weight: | 502.59 |
Synonyms: | U 4905;Cortisol,21-(hydrogen succinate), monosodium salt (8CI);Cortisol, succinate, sodium salt (6CI);A-HydroCort;Buccalsone;Corlan;Cortisol hemisuccinate sodium salt;Cortisol sodium hemisuccinate;Cortisolsodium succinate;EF-Cortelan Soluble;Emi-Corlin;Flebocortid;Hydrocortisone21-hemisuccinate sodium salt;Hydrocortisone 21-succinate sodium salt;Hydrocortisone hemisuccinate sodium salt;Hydrocortisone sodiumsuccinate;Intracort;Nordicort;Oralsone;Sodium 17-hydroxycorticosterone 21-succinate;Sodium hydrocortisone 21-hemisuccinate;Solu-Cortef;Solu-Glyc;Hydrocortisone sodium succinate; |
EINECS: | 204-725-5 |
Melting Point: | 169.0-171.2° |
Boiling Point: | 685.5 °C at 760 mmHg |
Flash Point: | 231.1 °C |
Solubility: | H2O: 50 mg/mL |
PSA: | 141.03000 |
LogP: | 0.86260 |
What can I do for you?
Get Best Price
The Hydrocortisone sodium succinate, with the CAS registry number 125-04-2, is also known as 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 21-hemisuccinate sodium salt. Its EINECS registry number is 204-725-5. This chemical's molecular formula is C25H33NaO8 and molecular weight is 484.51449. Its IUPAC name is called sodium 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate. This chemical which is used as a pharmaceutical intermediate should be stored at - 20 °C. This chemical's classification codes are Drug / Therapeutic Agent; Glucocorticoid; Human Data; Reproductive Effect.
Physical properties of Hydrocortisone sodium succinate are: (1)ACD/LogP: 2.13; (2)#H bond acceptors: 8; (3)#H bond donors: 3; (4)#Freely Rotating Bonds: 9; (5)Flash Point: 231.1 °C; (6)Enthalpy of Vaporization: 114.97 kJ/mol; (7)Boiling Point: 685.5 °C at 760 mmHg; (8)Vapour Pressure: 9.36E-22 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@H]4[C@H]([C@@H](O)C[C@]12C)[C@@]3(/C(=C\C(=O)CC3)CC4)C
(2)InChI: InChI=1/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/q;+1/p-1/t16-,17-,18-,22+,23-,24-,25-;/m0./s1
(3)InChIKey: HHZQLQREDATOBM-HVZBPSDKBG
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | LDLo | intravenous | 1429ug/kg (1.429mg/kg) | CARDIAC: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Medical Journal of Australia. Vol. 154, Pg. 782, 1991. |
man | TDLo | intravenous | 2857ug/kg (2.857mg/kg) | LUNGS, THORAX, OR RESPIRATION: BRONCHIOLAR CONSTRICTION GASTROINTESTINAL: NAUSEA OR VOMITING BLOOD: OXIDANT RELATED (GPD DEFICIENT) ANEMIA | Medical Journal of Australia. Vol. 154, Pg. 210, 1991. |
mouse | LD50 | intraperitoneal | 1050mg/kg (1050mg/kg) | Drugs in Japan Vol. 6, Pg. 625, 1982. | |
rat | LD50 | intraperitoneal | 1320mg/kg (1320mg/kg) | Drugs in Japan Vol. 6, Pg. 625, 1982. |